Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

MEROPENEM IV 500 MG VIAL

MEROPENEM
$2.8678per EA

Strength

500 mg/20mL

Manufacturer

Civica, Inc.

NDC

72572041510

Classification

Generic

Dosage Form

INJECTION

Route

INTRAVENOUS

Last Updated

5/22/2024

Active Ingredients

MEROPENEM

Approval Type

Generic (ANDA)

FDA Application

ANDA206086

On Market Since

9/23/2020

Pharmacological Classes

Carbapenems
Penem Antibacterial

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

-23.7%

Generic Alternatives

2 alternatives • Same active ingredient

MEROPENEM IV 500 MG VIAL
Generic
00781300095•Sandoz Inc.
$2.8678
MEROPENEM IV 500 MG VIAL
Generic
70594007502•Xellia Pharmaceuticals USA LLC
$2.8678

Related Drugs

Same classification

MEROPENEM IV 500 MG VIAL
Generic
00143943010•Hikma Pharmaceuticals USA Inc.
$2.8678
per EA
MEROPENEM IV 500 MG VIAL
Generic
00409022210•Hospira Inc.
$2.8678
per EA
MEROPENEM IV 500 MG VIAL
Generic
00409139051•Hospira Inc.
$2.8678
per EA
MEROPENEM IV 500 MG VIAL
Generic
44567014510•WG Critical Care, LLC
$2.8678
per EA
MEROPENEM IV 500 MG VIAL
Generic
44567040010•WG Critical Care, LLC
$2.8678
per EA
MEROPENEM IV 500 MG VIAL
Generic
55150020720•Eugia US LLC
$2.8678
per EA
MEROPENEM IV 500 MG VIAL
Generic
63323050720•Fresenius Kabi USA, LLC
$2.8678
per EA
MEROPENEM IV 500 MG VIAL
Generic
63323050721•Fresenius Kabi USA, LLC
$2.8678
per EA
MEROPENEM IV 500 MG VIAL
Generic
70121145407•Amneal Pharmaceuticals LLC
$2.8678
per EA
MEROPENEM IV 1 GM VIAL
Generic
00143943110•Hikma Pharmaceuticals USA Inc.
$5.5712
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy